Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04339374 · ClinicalTrials.gov registry record · NA
Ultrasound and Photoacoustic Imaging for Enhanced Differential Diagnosis of Rectal Cancer
A NA study of Colorectal Cancer and Rectal Cancer, sponsored by Washington University School of Medicine.
- Recruiting
- Registry status
- NA
- Development phase
- 90
- Enrollment target
- 1
- Study location
NCT04339374: Recruiting NA study of Colorectal Cancer and Rectal Cancer, sponsored by Washington University School of Medicine.
NCT04339374 is a NA study of Colorectal Cancer and Rectal Cancer that is actively recruiting participants, run by Washington University School of Medicine. The registered enrollment target is 90 participants, below the 1,544-participant average among 381 other Colorectal Cancer trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04339374, a NA study of Colorectal Cancer and Rectal Cancer, is actively recruiting participants, sponsored by Washington University School of Medicine.
- RECRUITING
- Registry status
- NA
- Development phase
- 90 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to demonstrate the functionality of a novel endorectal photoacoustic ultrasound imaging modality in humans with rectal cancer. The study involves testing a previously developed endorectal device to determine its ability to accurately assess rectal tumor response to preoperative treatment. Investigators hypothesize that a co-registered photoacoustic ultrasound endorectal device can significantly reduce unnecessary surgeries in rectal cancer patients with complete clinical response while maintaining high sensitivity in identifying those with residual cancer.
Primary Outcome
The primary endpoint is to see if the readers trained to use the co-registered PAM/US data are able to diagnose rectal cancers with better sensitivity \& specificity using surgery pathology results as the ground truth. SOC sensitivity and specificity will be computed based on readers' cCR vs. non-cCR. The sensitivity and specificity with additional PAM/US data will be computed based on readers' revised cCR vs. non-cCR. PAM/US model sensitivity and specificity will also be computed using surgery
Conditions Studied
Interventions
- DEVICE Photoacoustic imaging, photoacoustic microscopy
- DEVICE Endorectal photoacoustic imaging probe
- OTHER Reader Performance
Study Locations (1)
Missouri
- Washington University School of Medicine - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2023-05-01 |
| Est. Completion | 2028-12-31 |
| Phase | NA |
What NCT04339374 shows while recruiting
NCT04339374 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 90 participants, a relatively small participant target, below the 1,544-participant average among 381 other Colorectal Cancer trials with a reported enrollment target (94% lower).
The record links to 2 conditions, with Colorectal Cancer appearing as the primary indexed condition, and to 3 interventions - of which Photoacoustic imaging, photoacoustic microscopy is the first listed.
NCT04339374 reports a single indexed study location in Missouri.
Frequently Asked Questions
What is clinical trial NCT04339374 about?
NCT04339374 is a clinical study titled "Ultrasound and Photoacoustic Imaging for Enhanced Differential Diagnosis of Rectal Cancer". The purpose of this study is to demonstrate the functionality of a novel endorectal photoacoustic ultrasound imaging modality in humans with rectal cancer. The study involves testing a previously developed endorectal device to determine its ability to accurately assess rectal tumor response to preop...
What is the current status of trial NCT04339374?
This trial is currently recruiting. It is a NA study. The enrollment target is 90 participants. The study started on 2023-05-01. Estimated completion is 2028-12-31.
What conditions does trial NCT04339374 study?
This clinical trial studies the following conditions: Colorectal Cancer, Rectal Cancer.
What interventions are being tested in trial NCT04339374?
The interventions under investigation include: Photoacoustic imaging, photoacoustic microscopy (DEVICE), Endorectal photoacoustic imaging probe (DEVICE), Reader Performance (OTHER).
Who is sponsoring clinical trial NCT04339374?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04339374 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Colorectal Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04339374's enrollment target sits among peer trials
90 225th of 381 higher than 156 of 381 other Colorectal Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Colorectal Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Cross-sectional Partnership to Improve Prevention and Health Equity Among African Americans
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
-
Resistance Exercise and Creatine in Colorectal Cancer
RECRUITING · NA
-
Optimal Perioperative Pain Control in Minimally Invasive Abdominal Cancer Surgery
RECRUITING · NA
-
Mediterranean Diet and Weight Loss: Targeting the Bile Acid/Gut Microbiome Axis to Reduce Colorectal Cancer
RECRUITING · NA
-
PROGRESS: Precision Oncology Using Genomic Reflexive Evaluations for Study Selection and Survival
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02521311 · 90 participants · Phase 2
Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)
- NCT02939573 · 90 participants · Phase 2
A Randomized Multicenter Study for Isolated Skin Vasculitis
- NCT03128879 · 90 participants · Phase 2
Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL
- NCT03184038 · 90 participants · NA
Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI